Immune cell dysfunction and inflammation in end-stage renal disease.
about
Extracellular vesicles as mediators of vascular inflammation in kidney diseasePentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-AnalysisInfluenza and the patient with end-stage renal disease.Bacteraemia in haemodialysis patients--not always Staphylococcus aureus.Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction IntervalsPotential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients.Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysisAssociation of inflammatory cytokines with mortality in peritoneal dialysis patients.Pre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients.Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD).Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patientsA study of the immunoloregulation of double filtration plasmapheresis in maintenance hemodialysis patients with chronic hepatitis C.Hepatic and pancreatic resection in patients with end-stage renal disease: a propensity analysis.A brief journey through the immune system.Loss of CD28 on Peripheral T Cells Decreases the Risk for Early Acute Rejection after Kidney Transplantation.Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis.Hemodialysis Is Associated With Increased Peripheral Artery Occlusive Disease Risk Among Patients With End-Stage Renal Disease: A Nationwide Population-Based Cohort Study.Vitamin D receptor activation reduces inflammatory cytokines and plasma MicroRNAs in moderate chronic kidney disease - a randomized trial.Mortality among Younger and Older Recipients of Kidney Transplants from Expanded Criteria Donors Compared with Standard Criteria DonorsAdvanced chronic kidney disease: a strong risk factor for Clostridium difficile infectionDNA methylation profiling reveals differences in the 3 human monocyte subsets and identifies uremia to induce DNA methylation changes during differentiationDynamics of naturally acquired antibody against Haemophilus influenzae type a capsular polysaccharide in a Canadian Aboriginal population.Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A.Unusual CD4+CD28- T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders.Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia.Increased Neutrophil Extracellular Trap Formation in Uremia Is Associated with Chronic Inflammation and Prevalent Coronary Artery Disease.Costimulatory pathways in kidney transplantation: pathogenetic role, clinical significance and new therapeutic opportunities.T-cell ageing in end-stage renal disease patients: Assessment and clinical relevance.Chronic kidney disease and premature ageing of the adaptive immune response.Persistent dilemmas in zoster eye disease.The Risks of Incident and Recurrent Clostridium difficile-Associated Diarrhea in Chronic Kidney Disease and End-Stage Kidney Disease Patients: A Systematic Review and Meta-Analysis.High convection volume in online post-dilution haemodiafiltration: relevance, safety and costs.Clinical consequences of circulating CD28-negative T cells for solid organ transplantation.Predialysis chronic kidney disease correlates with increased risk of pyogenic liver abscess: a population-based cohort study.The role of age-related T-cell differentiation in patients with renal replacement therapy.Sodium chloride promotes tissue inflammation via osmotic stimuli in subtotal-nephrectomized mice.Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options.Targeting the complement cascade: novel treatments coming down the pike.The effect of chronic kidney disease on T cell alloimmunity.Cardiovascular disease in haemodialysis: role of the intravascular innate immune system.
P2860
Q26765072-E3C197A1-CABA-46D9-BDF7-C2819649B891Q26799740-7F8A1868-2EDD-473C-B91E-414D12C8ACEFQ30252363-EFF06F18-D740-4074-B473-8C2E4E7D2486Q30316474-4ED1C487-6CCB-4D72-B9B3-91F6C3005198Q30749748-BDBDAC95-0E11-46B4-9EB6-75A4DF4B7F2AQ33604689-63A37680-EE5A-4954-80F4-0D3808948FFCQ33648836-CAA32716-60FE-48EC-9877-A81FFD51DA2FQ33712005-9FDEC006-5781-4484-BC04-62AF63622AE8Q33745763-48F76A21-93EC-4F2D-9EFC-477CA267C9F5Q33780032-26071F5C-EF6F-4ADF-92C5-FF2C459E96FDQ34168451-DFB6A2AE-FCF2-4EFC-80C4-C6F74605E0A7Q35072818-5581F25C-60E4-49EE-A255-0F10CB01CC8DQ35805867-183A0B8A-CF3E-4CB9-A596-3E33B6BE538BQ35817039-252577E6-99C3-4E35-B365-E6D057B51F70Q35948016-E06B24C9-94D8-45FD-8894-4A8581669FE6Q36004544-3B63AF85-C507-464C-93A5-163CEEFD7B81Q36196671-A6B90950-B7F0-4561-9F23-39D49DC56D35Q36373525-9D046371-C3AB-4A63-8808-429E718CBA1DQ36432878-F23E2DA5-12B1-4DAD-8A08-99FE450B0446Q36461103-AD7A2610-3201-408C-8E6B-C87C0FB92B27Q36957027-4389BF5B-2780-40D9-BECE-7E771D569E4FQ37056867-FD78CE18-EB15-44EF-B324-0493514E3E65Q37358482-0FBE88D8-89A5-4324-8272-11E12E1C1CDBQ37541433-45DA55CD-7B64-48F7-A98D-9BBC32126E76Q37640920-C0119FE9-281D-4DCB-8CF1-AB095D57B7E8Q37744091-85CA609C-580F-4948-833D-F5B4EC42DC37Q38152797-8BB3F5F0-FA78-435D-99D8-F55576C3D0EBQ38265548-27E29D9F-90F5-4391-9775-B1E6BB78562EQ38268945-E39DF2A0-4286-45B9-813B-E6383A16B1ADQ38475791-6C4D4B9E-DB6C-4ECB-8CB0-BB6CF4029C94Q38489324-89723799-2F66-450B-AC89-4F0FFCD2CDDCQ38562316-C0EB47F4-FBC8-447E-8375-750A67FC6414Q38568848-8AC959E1-4E77-4E6F-A8A6-D337F413A073Q38644250-9C720090-6D19-4DA0-9993-1F4999C78315Q38672633-40CCC2D5-01D6-4877-BB17-D805FDB8C3DFQ38717770-1B443FC2-5FCC-4194-8FEB-6FEE918F9C79Q38757951-84604109-EB86-441F-B483-32525A9765E5Q38850489-B3E6EC71-BFAD-436C-8608-A276A7258C76Q39031609-6327D196-367C-487E-8222-219418638CAEQ39151839-BC3E9C56-67CE-4076-899C-C0E7CB6165AE
P2860
Immune cell dysfunction and inflammation in end-stage renal disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immune cell dysfunction and inflammation in end-stage renal disease.
@en
type
label
Immune cell dysfunction and inflammation in end-stage renal disease.
@en
prefLabel
Immune cell dysfunction and inflammation in end-stage renal disease.
@en
P2860
P356
P1476
Immune cell dysfunction and inflammation in end-stage renal disease.
@en
P2093
Michiel G H Betjes
P2860
P2888
P304
P356
10.1038/NRNEPH.2013.44
P407
P577
2013-03-19T00:00:00Z
P6179
1037614149